May 12, 2011
/PRNewswire/ -- Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in
, will host a conference call on
Tuesday, May 17
Eastern to discuss its financial results for the first quarter ended
March 31, 2011
. Tibet's Form 10-Q and corresponding earnings release are expected to be filed on
May 16, 2011
"We look forward to discussing our latest financial performance during our upcoming conference call," said
, Chief Executive Officer of Tibet Pharmaceuticals. "Tibet has consistently delivered strong revenue and earnings growth, and this was the case again not more than a month ago when we reported our record financial results for the 2010 fiscal year. As we continue to focus on our organic growth while implementing potential future acquisitions, we believe this trend will accelerate in 2011."
The teleconference can be accessed by dialing 877-407-0778 when calling within
the United States
or 201-689-8565 when calling internationally. Please dial in 10 minutes prior to the beginning of the call. There will be a playback available until
May 31, 2011
. To listen to the playback dial 877-660-6853 when calling within
the United States
, or 201-612-7415 when calling internationally and use account number: 286, in conjunction with replay ID number: 372828.
The conference call will be simultaneously webcast and available on the company's website,
, under the "Events and Presentations" tab of the "Investors" section.
About Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
. With over 190 employees and nation-wide distributors, the company develops both prescription and over-the-counter traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
, with a majority of sales concentrated in the southern provinces, most notably
, where the company's 52,000 sq. ft. GMP-certified manufacturing facilities are located. The access to key raw materials, not generally available outside the province, provides a significant advantage for Tibet Pharmaceuticals.
For comprehensive investor relations material, including fact sheets, research reports, presentations and video, please follow the appropriate link:
For more information on Tibet Pharmaceuticals, please visit: